Surgical evaluation in children <3 years of age with drug-resistant epilepsy: Patient characteristics, diagnostic utilization, and potential for treatment delays.
Michael Scott PerrySabrina ShandleyMax PerelmanRani K SinghLily Wong-KisielJoseph SullivanErnesto Gonzalez-GiraldoErin Fedak RomanowskiNancy A McNamaraAhmad MarashlyAdam P OstendorfAllyson AlexanderKrista EschbachJeffrey BoltonSteven WolfPatricia McGoldrickDewi F Depositario-CabacarMichael A CilibertoSatyanarayana GedelaKumar SannagowdaraSamir KariaDaniel W ShreyPriya TatacharSrishti NangiaZachary M GrinspanShilpa B ReddyPatel ShitalJason CoryellPublished in: Epilepsia (2021)
There are relatively few studies of epilepsy surgery in the very young. Surgery is effective, but may be disproportionally offered to those with severe presentations. Relatively low utilization of ancillary testing may contribute to reduced surgical therapy for those without evident lesions on magnetic resonance imaging. Despite this, a sizeable portion of patients have favorable outcome after focal epilepsy surgery resections.
Keyphrases
- drug resistant
- minimally invasive
- coronary artery bypass
- magnetic resonance imaging
- multidrug resistant
- surgical site infection
- end stage renal disease
- acinetobacter baumannii
- young adults
- newly diagnosed
- ejection fraction
- prognostic factors
- acute coronary syndrome
- percutaneous coronary intervention
- magnetic resonance
- patient reported outcomes
- atrial fibrillation
- patient reported